KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
110 hedge funds and large institutions have $631M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 9 closing their positions.
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
41% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 32
6% more funds holding
Funds holding: 104 → 110 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $713M → $631M (-$82.1M)
97% less call options, than puts
Call options by funds: $66K | Put options by funds: $2.05M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$16.7M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$5.36M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.91M |
| 5 |
SM
Senvest Management
New York
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$9.82M |
| 2 |
HM
HealthCor Management
New York
|
-$2.06M |
| 3 |
SAM
Senzar Asset Management
New York
|
-$2.06M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.63M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$1.39M |
KYTH Hedge Fund Activity: Q3 2014 in Review
110 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q3 2014, worth a combined $631M — down 12% from $713M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new KYTH positions and 9 closed out — a net gain of 6 holders — while 45 added to existing stakes and 32 trimmed.
The largest buyer was Kornitzer Capital Management, adding an estimated $16.7M. The largest seller was Redmile Group, cutting an estimated $9.82M.
- 110 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q3 2014, up from 104 in Q2 2014.
- Funds reported $631M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q3 2014, down 12% quarter-over-quarter.
- 15 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q3 2014 and 9 closed out, a net change of +6 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q3 2014 was Kornitzer Capital Management, an estimated $16.7M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q3 2014 was Redmile Group, an estimated $9.82M sold.
Based on aggregated 13F filings for Q3 2014.